195 related articles for article (PubMed ID: 25689812)
21. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis.
Tan WP; Suresh S; Tey HL; Chiam LY; Goon AT
Clin Exp Dermatol; 2010 Jun; 35(4):e109-12. PubMed ID: 19843084
[TBL] [Abstract][Full Text] [Related]
22. An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.
Mengeaud V; Phulpin C; Bacquey A; Boralevi F; Schmitt AM; Taieb A
Pediatr Dermatol; 2015; 32(2):208-15. PubMed ID: 25529232
[TBL] [Abstract][Full Text] [Related]
23. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
[TBL] [Abstract][Full Text] [Related]
24. Barrier repair therapy for facial atopic eczema with a non-steroidal emollient cream containing rhamnosoft, ceramides and iso-leucine. A six-case report series.
Puviani M; Agostinis F; Milani M
Minerva Pediatr; 2014 Aug; 66(4):307-11. PubMed ID: 25198568
[TBL] [Abstract][Full Text] [Related]
25. A randomized, investigator-blinded efficacy assessment study of stand-alone emollient use in mild to moderately severe atopic dermatitis flares.
Angelova-Fischer I; Neufang G; Jung K; Fischer TW; Zillikens D
J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 3():9-15. PubMed ID: 24702445
[TBL] [Abstract][Full Text] [Related]
26. [Study of tolerance and efficacy of cosmetic preparations with lenitive action in atopic dermatitis in children].
Grassi A; Palermi G; Paradisi M
Clin Ter; 2000; 151(2):77-80. PubMed ID: 10876973
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis.
Gayraud F; Sayag M; Jourdan E
J Cosmet Dermatol; 2015 Jun; 14(2):107-12. PubMed ID: 25807867
[TBL] [Abstract][Full Text] [Related]
28. Prevention of Flares in Children with Atopic Dermatitis with Regular Use of an Emollient Containing Glycerol and Paraffin: A Randomized Controlled Study.
Tiplica GS; Kaszuba A; Malinauskienė L; Konno P; Boralevi F; Garrigue E; Saint-Aroman M; Delarue A
Pediatr Dermatol; 2017 May; 34(3):282-289. PubMed ID: 28271540
[TBL] [Abstract][Full Text] [Related]
29. Questionnaire survey of the efficacy of emollients for adult patients with atopic dermatitis.
Kawakami T; Soma Y
J Dermatol; 2011 Jun; 38(6):531-5. PubMed ID: 21352299
[TBL] [Abstract][Full Text] [Related]
30. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study.
Grimalt R; Mengeaud V; Cambazard F;
Dermatology; 2007; 214(1):61-7. PubMed ID: 17191050
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.
Cabout E; Eymere S; Launois R; Séité S; Delvigne V; Taïeb C; Reguai Z
Acta Derm Venereol; 2021 Jul; 101(7):adv00509. PubMed ID: 34230978
[TBL] [Abstract][Full Text] [Related]
32. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
33. Quality of life of parents living with a child suffering from atopic dermatitis before and after a 3-month treatment with an emollient.
Gelmetti C; Boralevi F; Seité S; Grimalt R; Humbert P; Luger T; Stalder JF; Taïeb A; Tennstedt D; Garcia Diaz R; Rougier A
Pediatr Dermatol; 2012; 29(6):714-8. PubMed ID: 23106672
[TBL] [Abstract][Full Text] [Related]
34. Pharmacoeconomics of drug therapy for atopic dermatitis.
Lamb SR; Rademaker M
Expert Opin Pharmacother; 2002 Mar; 3(3):249-55. PubMed ID: 11866675
[TBL] [Abstract][Full Text] [Related]
35. Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis.
Cabout E; Eymere S; Launois R; Aslanian F; Taïeb C; Seité S
Clin Cosmet Investig Dermatol; 2020; 13():987-996. PubMed ID: 33376376
[TBL] [Abstract][Full Text] [Related]
36. Online survey to identify current challenges in atopic dermatitis management and guideline implementation in German-speaking countries.
Traidl S; Heratizadeh A; Werfel T; Dressler C
Eur J Dermatol; 2021 Dec; 31(6):806-812. PubMed ID: 35107071
[TBL] [Abstract][Full Text] [Related]
37. A nonsteroidal lamellar matrix cream containing palmitoylethanolamide for the treatment of atopic dermatitis.
Kircik L
J Drugs Dermatol; 2010 Apr; 9(4):334-8. PubMed ID: 20514790
[TBL] [Abstract][Full Text] [Related]
38. Emollients for preventing atopic eczema: Cost-effectiveness analysis of the BEEP trial.
Sach TH; Lartey ST; Davies C; Chalmers JR; Haines RH; Bradshaw LE; Montgomery AA; Thomas KS; Brown SJ; Ridd MJ; Lawton S; Cork MJ; Flohr C; Mitchell E; Swinden R; Wyatt L; Tarr S; Davies-Jones S; Jay N; Kelleher MM; Perkin MR; Boyle RJ; Williams HC;
Clin Exp Allergy; 2023 Oct; 53(10):1011-1019. PubMed ID: 37574761
[TBL] [Abstract][Full Text] [Related]
39. Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.
Wollenberg A; Fölster-Holst R; Saint Aroman M; Sampogna F; Vestergaard C
J Eur Acad Dermatol Venereol; 2018 Apr; 32 Suppl 1():1-15. PubMed ID: 29533490
[TBL] [Abstract][Full Text] [Related]
40. Prolonging Time to Flare in Pediatric Atopic Dermatitis: A Randomized, Investigator-Blinded, Controlled, Multicenter Clinical Study of a Ceramide-Containing Moisturizer.
Ma L; Li P; Tang J; Guo Y; Shen C; Chang J; Kerrouche N
Adv Ther; 2017 Dec; 34(12):2601-2611. PubMed ID: 29143926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
